National Asset Recovery Corp.
REPO News Today: Stay Updated with the Latest National Asset Recovery Corp. News in Real Time
Find REPO news now at Meyka AI. Stay informed with the latest National Asset Recovery Corp. stocks updates, including price news, market analysis, and expert insights.
ALL.AX Stock Falls 2.1% Pre-Market as Earnings Loom on 13 May 2026
ALL.AX drops 2.1% to A$45.85 ahead of earnings announcement. Aristocrat Leisure faces headwinds despite strong cash flow metrics.
SOUN Stock Down 9.6% on May 12, 2026 – SoundHound AI Faces Headwinds
SOUN stock fell 9.6% to $8.03 on May 12, 2026. SoundHound AI faces profitability challenges despite analyst support and institutional buying.
ZOMATO.NS Stock Flat at ₹215.19 on NSE Pre-Market, May 13
ZOMATO.NS stock at ₹215.19 in pre-market trading. Explore key metrics, market sentiment, and AI analysis for this NSE-listed food delivery leader.
ALDNE.PA Surges 13.16% as Don’t Nod Entertainment Rebounds on Volume
ALDNE.PA stock jumps 13.16% to €0.43 on high volume of 37,468 shares. Don’t Nod Entertainment rebounds despite long-term challenges.
4689.T Stock Drops 6.8% in Pre-Market; LY Corporation Faces Selling Pressure
LY Corporation (4689.T) falls 6.8% to ¥410.1 in pre-market trading on JPX. Volume surges 48% above average as investors reassess positions.
WHO Director Election May 13: New Chief Selection Process Begins
WHO Director-General election opens May 2026 with new ethical guidelines for selecting the next global health leader.
GAG.DE Stock Surges 900% on XETRA: GORE German Office Real Estate
GAG.DE stock jumps 900% to €0.76 on XETRA. GORE German Office Real Estate AG faces challenges with negative earnings and high volatility in May 2026.
XIGM.CN stock plunges 46% on May 12, 2026 amid tech sector weakness
XIGM.CN stock crashes 46.15% to C$0.035 on May 12, 2026. Xigem Technologies faces severe headwinds with negative earnings and weak fundamentals.
ALNA stock rises 3.16% on heavy trading volume May 12
ALNA stock gained 3.16% to $0.075 on May 12 with 252M shares traded. Allena Pharmaceuticals faces steep long-term declines.